Trinity Biotech | TRIB - Ativos





Ativos Alterar Data
Abbott USD 110.43B 23.72B 2026-03
Bayer EUR 107.94B 3.4B 2026-03
Bio-Rad Laboratories USD 9.79B 786.5M 2026-03
EDAP TMS EUR 61.46M 6.88M 2025-09
J&J USD 200.89B 1.68B 2026-03
Mesa Laboratories USD 434.85M 4.5M 2025-12
OraSure Technologies USD 379.17M 24M 2026-03
Plus Therapeutics USD 19.92M 3.59M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
Siemens EUR 167.97B 2.16B 2026-03
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Tosoh JPY 1.41T 64.61B 2026-03
Trinity Biotech USD 105.16M 1.45M 2025-12
Veracyte USD 1.44B 30.38M 2026-03